MiR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT

C. J. Kao, A. Martiniez, X. B. Shi, J. Yang, C. P. Evans, A. Dobi, R. W. Devere White, H. J. Kung

Research output: Contribution to journalArticle

98 Citations (Scopus)

Abstract

Src tyrosine kinase (Src) is implicated in the development of bone metastasis and castration resistance of prostate cancer. Src inhibitors are currently being tested in clinical trials for such diseases. Understanding the molecular and cellular actions of Src inhibitors holds the key to future improvement of this line of therapy. Here we describe the microRNA expression profiles modulated by two Src inhibitors and demonstrate that the miR-30 family members are the most prominently induced species. Consistent with its tumor suppressor role, miR-30 is downmodulated by oncogenic signals such as epidermal growth factor (EGF) and hepatocyte growth factor, and is generally underexpressed in prostate cancer specimens. A number of epithelial-to- mesenchymal transition (EMT)-associated genes are predicted targets of miR-30. Among these genes the Ets-related gene (ERG) is the most frequently overexpressed oncogene in prostate cancer activated by genomic fusion events between promoter upstream sequences of the TMPRSS2 and coding sequences of ERG. We showed by ERG 3′ untranslated region reporter and mutagenesis assays that ERG is a direct target of miR-30. Overexpression of miR-30 in prostate cancer cells suppresses EMT phenotypes and inhibits cell migration and invasion. It also inhibits the in vitro and in vivo growth of VCaP cells, which depends on TMPRSS2-ERG for proliferation. TMPRSS2-ERG is generally regulated by androgen at the transcriptional level. Our finding reveals a new post-transcriptional mechanism of TMPRSS2-ERG regulation by Src and growth signals via miR-30 providing a rationale for targeting ERG-positive castration-resistant tumors with Src inhibitors.

Original languageEnglish
Pages (from-to)2495-2503
Number of pages9
JournalOncogene
Volume33
Issue number19
DOIs
Publication statusPublished - May 8 2014

Fingerprint

Epithelial-Mesenchymal Transition
Epidermal Growth Factor
Genes
Neoplasms
Prostatic Neoplasms
Castration
src Genes
Hepatocyte Growth Factor
src-Family Kinases
Bone Development
3' Untranslated Regions
Growth
MicroRNAs
Oncogenes
Mutagenesis
Androgens
Cell Movement
Clinical Trials
Neoplasm Metastasis
Phenotype

Keywords

  • EGF
  • ERG and EMT
  • miRNA
  • prostate cancer
  • Src

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Kao, C. J., Martiniez, A., Shi, X. B., Yang, J., Evans, C. P., Dobi, A., ... Kung, H. J. (2014). MiR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT. Oncogene, 33(19), 2495-2503. https://doi.org/10.1038/onc.2013.200

MiR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT. / Kao, C. J.; Martiniez, A.; Shi, X. B.; Yang, J.; Evans, C. P.; Dobi, A.; Devere White, R. W.; Kung, H. J.

In: Oncogene, Vol. 33, No. 19, 08.05.2014, p. 2495-2503.

Research output: Contribution to journalArticle

Kao, CJ, Martiniez, A, Shi, XB, Yang, J, Evans, CP, Dobi, A, Devere White, RW & Kung, HJ 2014, 'MiR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT', Oncogene, vol. 33, no. 19, pp. 2495-2503. https://doi.org/10.1038/onc.2013.200
Kao CJ, Martiniez A, Shi XB, Yang J, Evans CP, Dobi A et al. MiR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT. Oncogene. 2014 May 8;33(19):2495-2503. https://doi.org/10.1038/onc.2013.200
Kao, C. J. ; Martiniez, A. ; Shi, X. B. ; Yang, J. ; Evans, C. P. ; Dobi, A. ; Devere White, R. W. ; Kung, H. J. / MiR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT. In: Oncogene. 2014 ; Vol. 33, No. 19. pp. 2495-2503.
@article{6b5d4b35ff6146efa863f3cfbabb6fc9,
title = "MiR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT",
abstract = "Src tyrosine kinase (Src) is implicated in the development of bone metastasis and castration resistance of prostate cancer. Src inhibitors are currently being tested in clinical trials for such diseases. Understanding the molecular and cellular actions of Src inhibitors holds the key to future improvement of this line of therapy. Here we describe the microRNA expression profiles modulated by two Src inhibitors and demonstrate that the miR-30 family members are the most prominently induced species. Consistent with its tumor suppressor role, miR-30 is downmodulated by oncogenic signals such as epidermal growth factor (EGF) and hepatocyte growth factor, and is generally underexpressed in prostate cancer specimens. A number of epithelial-to- mesenchymal transition (EMT)-associated genes are predicted targets of miR-30. Among these genes the Ets-related gene (ERG) is the most frequently overexpressed oncogene in prostate cancer activated by genomic fusion events between promoter upstream sequences of the TMPRSS2 and coding sequences of ERG. We showed by ERG 3′ untranslated region reporter and mutagenesis assays that ERG is a direct target of miR-30. Overexpression of miR-30 in prostate cancer cells suppresses EMT phenotypes and inhibits cell migration and invasion. It also inhibits the in vitro and in vivo growth of VCaP cells, which depends on TMPRSS2-ERG for proliferation. TMPRSS2-ERG is generally regulated by androgen at the transcriptional level. Our finding reveals a new post-transcriptional mechanism of TMPRSS2-ERG regulation by Src and growth signals via miR-30 providing a rationale for targeting ERG-positive castration-resistant tumors with Src inhibitors.",
keywords = "EGF, ERG and EMT, miRNA, prostate cancer, Src",
author = "Kao, {C. J.} and A. Martiniez and Shi, {X. B.} and J. Yang and Evans, {C. P.} and A. Dobi and {Devere White}, {R. W.} and Kung, {H. J.}",
year = "2014",
month = "5",
day = "8",
doi = "10.1038/onc.2013.200",
language = "English",
volume = "33",
pages = "2495--2503",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "19",

}

TY - JOUR

T1 - MiR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT

AU - Kao, C. J.

AU - Martiniez, A.

AU - Shi, X. B.

AU - Yang, J.

AU - Evans, C. P.

AU - Dobi, A.

AU - Devere White, R. W.

AU - Kung, H. J.

PY - 2014/5/8

Y1 - 2014/5/8

N2 - Src tyrosine kinase (Src) is implicated in the development of bone metastasis and castration resistance of prostate cancer. Src inhibitors are currently being tested in clinical trials for such diseases. Understanding the molecular and cellular actions of Src inhibitors holds the key to future improvement of this line of therapy. Here we describe the microRNA expression profiles modulated by two Src inhibitors and demonstrate that the miR-30 family members are the most prominently induced species. Consistent with its tumor suppressor role, miR-30 is downmodulated by oncogenic signals such as epidermal growth factor (EGF) and hepatocyte growth factor, and is generally underexpressed in prostate cancer specimens. A number of epithelial-to- mesenchymal transition (EMT)-associated genes are predicted targets of miR-30. Among these genes the Ets-related gene (ERG) is the most frequently overexpressed oncogene in prostate cancer activated by genomic fusion events between promoter upstream sequences of the TMPRSS2 and coding sequences of ERG. We showed by ERG 3′ untranslated region reporter and mutagenesis assays that ERG is a direct target of miR-30. Overexpression of miR-30 in prostate cancer cells suppresses EMT phenotypes and inhibits cell migration and invasion. It also inhibits the in vitro and in vivo growth of VCaP cells, which depends on TMPRSS2-ERG for proliferation. TMPRSS2-ERG is generally regulated by androgen at the transcriptional level. Our finding reveals a new post-transcriptional mechanism of TMPRSS2-ERG regulation by Src and growth signals via miR-30 providing a rationale for targeting ERG-positive castration-resistant tumors with Src inhibitors.

AB - Src tyrosine kinase (Src) is implicated in the development of bone metastasis and castration resistance of prostate cancer. Src inhibitors are currently being tested in clinical trials for such diseases. Understanding the molecular and cellular actions of Src inhibitors holds the key to future improvement of this line of therapy. Here we describe the microRNA expression profiles modulated by two Src inhibitors and demonstrate that the miR-30 family members are the most prominently induced species. Consistent with its tumor suppressor role, miR-30 is downmodulated by oncogenic signals such as epidermal growth factor (EGF) and hepatocyte growth factor, and is generally underexpressed in prostate cancer specimens. A number of epithelial-to- mesenchymal transition (EMT)-associated genes are predicted targets of miR-30. Among these genes the Ets-related gene (ERG) is the most frequently overexpressed oncogene in prostate cancer activated by genomic fusion events between promoter upstream sequences of the TMPRSS2 and coding sequences of ERG. We showed by ERG 3′ untranslated region reporter and mutagenesis assays that ERG is a direct target of miR-30. Overexpression of miR-30 in prostate cancer cells suppresses EMT phenotypes and inhibits cell migration and invasion. It also inhibits the in vitro and in vivo growth of VCaP cells, which depends on TMPRSS2-ERG for proliferation. TMPRSS2-ERG is generally regulated by androgen at the transcriptional level. Our finding reveals a new post-transcriptional mechanism of TMPRSS2-ERG regulation by Src and growth signals via miR-30 providing a rationale for targeting ERG-positive castration-resistant tumors with Src inhibitors.

KW - EGF

KW - ERG and EMT

KW - miRNA

KW - prostate cancer

KW - Src

UR - http://www.scopus.com/inward/record.url?scp=84900441668&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900441668&partnerID=8YFLogxK

U2 - 10.1038/onc.2013.200

DO - 10.1038/onc.2013.200

M3 - Article

C2 - 23728339

AN - SCOPUS:84900441668

VL - 33

SP - 2495

EP - 2503

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 19

ER -